Evidence map›Paper›PMID 40032954›Full record

ArticleScientific reports2025

Geometry-encoded molecular dynamics enables deep learning insights into P450 regiospecificity control.

Denis Pompon, Luis F Garcia-Alles, Philippe Urban

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Denis PomponToulouse Biotechnology Institute, Université de Toulouse, CNRS, INRAE, INSA, 135 Avenue de Rangueil, Toulouse, France. dpompon@insa-toulouse.fr.ORCID https://orcid.org/0000-0002-3431-3529
Luis F Garcia-AllesToulouse Biotechnology Institute, Université de Toulouse, CNRS, INRAE, INSA, 135 Avenue de Rangueil, Toulouse, France.ORCID https://orcid.org/0000-0002-1141-0393
Philippe UrbanToulouse Biotechnology Institute, Université de Toulouse, CNRS, INRAE, INSA, 135 Avenue de Rangueil, Toulouse, France.ORCID https://orcid.org/0000-0003-0557-839X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytochrome P450 1A2, as many isoenzymes, can generate multiple metabolites from a single substrate. A loose coupling between substrate binding and oxygen activation makes possible substrate reorientations at the active site prior to catalysis. In the present work, caffeine oxidation to alternative bioactive compounds was used to decipher this pluripotency. A model involving two interacting subsites capable of sequentially accommodating one or two caffeine molecules was considered. Molecular dynamics was used to characterize subsite interactions and feed a dedicated geometric encoding of trajectories that was coupled to dimensional reductions and differential machine learning. The two subsites differentially control caffeine orientations and can exchange substrate through a phenylalanine gated mechanism. This exchange can be locked by the presence of a second bound molecule. Complementary roles of subsites in progressively determining the caffeine orientation during its approach to active oxygen were examined. Interestingly, substrate face flipping becomes impaired upon entry into the rather flat active site. This makes the mechanisms that define the orientation of caffeine relative to active oxygen dependent on the substrate face oriented toward heme. Globally, this evidenced that P450 1A2 regioselectivity results from local determinants combined with subsite interactions and caffeine face preselection at a longer distance.

Indexed as

CaffeineCytochrome P-450 CYP1A2Deep LearningMolecular Dynamics SimulationCatalytic DomainHumansOxidation-ReductionOxygenSubstrate SpecificityCaffeineCytochrome P-450 CYP1A2OxygenCaffeineDeep learningGeometric encodingMolecular dynamicP450Regioselectivity

Identifiers

PMID40032954
PMCPMC11876329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.